PGIM India Healthcare Fund - Direct Plan - Growth Option

PGIM India Healthcare Fund - Direct Plan - Growth Option holds up reasonably well within the Sectoral/ Thematic category, backed by a 4-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 72/100.

Cost: At 0.8%, the expense ratio is meaningfully cheaper — about 26% below the Sectoral/ Thematic category average of 1.08% (based on 222 comparable funds). Lower costs compound in your favour over long holding periods.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.34 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 13.03% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.